Ministry of Economic Development Home| Contact MED|


 
 
 

Links to this page were:

Section Subnavigation Links:

Bioprospecting: New Zealand's International Commitments

[ Last Updated 16 December 2005 ]
Status:Archived

PowerPoint Presentation Slides
to the
Bioprospecting in New Zealand Seminar, 21 February 2003

Kristy Hall
University of Auckland
Master of Science student
School of Geography and Environmental Science

This presentation is also available in
PowerPoint (440 KB) and
Adobe Acrobat (433 KB) formats
(instructions for obtaining the Adobe Acrobat viewer)

Contents

Slide 1: 1.1 Overview

  • What is Bioprospecting?
  • An Issue of Significance to New Zealand
  • International Commitments
  • Conclusions

Slide 2: 2.1 What Is Bioprospecting?

Bioprospecting is:

"the examination of biological resources for features that may be of value for commercial development"

Slide 3: 2.2 What Is Bioprospecting?

  • Historically, bioprospecting has been conducted for centuries.
  • In the last twenty years bioprospecting has grown rapidly, fueled by technological advances in the pharmaceutical, biotechnology and agricultural sectors.

Slide 4: 2.3 What Is Bioprospecting?

Today, bioprospecting includes:

  • The search for new pharmaceuticals
  • The search for novel gene sequences or characteristics for biotechnology
  • The development of new ornamental plants and commercial crops

Slide 5: 2.4 What Is Bioprospecting?

Bioprospecting is BIG business!

Pharmaceuticals:US$300 billion
Agrochemicals and Seed:US$60 billion
Ornamental Horticulture:US$16-19 billion
Natural Medicines:US$10 billion

Slide 6: 3.1 An Issue of Significance to New Zealand

New Zealand is a prime target for bioprospecting

BUT…

At present there are no guidelines or regulations governing bioprospecting activities in New Zealand

Slide 7: 3.2 An Issue of Significance to New Zealand

Why New Zealand?

  • Unique biodiversity
  • Māori knowledge
  • Solid infrastructure

Slide 8: 4.1 International Commitments

There are no international agreements which specifically define or use the term "bioprospecting"

But a number do address the issues surrounding this activity

Current work on access and benefit sharing only focuses on bioprospecting occurring between countries

Slide 9: 4.2 International Commitments

At the international level New Zealand:

  • Is a Member of several international organisations developing relevant policy
  • Has signed a number of relevant international treaties and agreements. These are either binding or non-binding

Slide 10: 4.3 International Commitments

Examples of international organisations to which New Zealand is a Member:

  • Commission on Sustainable Development (CSD)
  • Food and Agricultural Organisation (FAO)
  • International Union for the Protection of Plant Varieties (UPOV)
  • World Intellectual Property Organisation (WIPO)
  • World Trade Organisation (WTO)

Slide 11: 4.4 International Commitments

Examples of binding international treaties to which New Zealand is a Party

  • Convention on Biological Diversity
  • Convention on International Trade in Endangered Species
  • Trade Related Aspects of Intellectual Property Rights
  • United Nations Convention on the Law of the Sea

We are also also a signatory to a number of non-binding political declarations e.g. the Rio Declaration, Agenda 21, and the WSSD Declaration.

Slide 12: 5.1 The Convention on Biological Diversity

*** A Groundbreaking Treaty!!! ***

Why?

  • The first international treaty to recognise state sovereignty over genetic resources
  • First treaty to include access and benefit sharing obligations

Slide 13: 5.2 The Convention on Biological Diversity

  • Drafted following growing concern over the impact of humankind on the environment
  • Signed at the 1992 Rio Earth Summit
  • 178 nations and the European Union have ratified

Slide 14: 5.3 The Convention on Biological Diversity

Objectives:

  • Conservation of biological diversity
  • Sustainable use of its components
  • The fair and equitable sharing of benefits arising from the utilisation of genetic resources

Slide 15: 5.4 The Convention on Biological Diversity

Relevance to bioprospecting management:

  • Establishes / reaffirms state sovereignty over natural resources
  • Requests that Parties facilitate access to genetic resources
  • Benefit sharing
  • Protection of traditional knowledge

Slide 16: 5.5 The Convention on Biological Diversity

Bonn Guidelines:

  • Voluntary
  • Aim to facilitate and guide policy development for access and benefit sharing
  • Application should "mutually support" existing international agreements

Slide 17: 5.6 The Convention on Biological Diversity

Bonn Guidelines: Key Recommendations

  • Prior informed consent
  • Mutually agreed terms for access and benefit sharing
  • Benefits may be monetary or non-monetary
  • Respect for indigenous peoples' culture

Slide 18: 6.1 WIPO and TRIPS

  • Aim to harmonise Intellectual Property law, promote innovation, and ensure that IP is not a barrier to international trade
  • Some argue that the provisions of WIPO and TRIPS conflict with the objectives of the CBD:
    • Permitting monopoly rights over biodiversity
    • Allowing the misappropriation of traditional knowledge
    • Inhibiting access and benefit sharing regimes

Slide 19: 6.2 WIPO and TRIPS

This has come to be known as

Biopiracy!!!

Slide 20: 7.1 Conclusions

  • Bioprospecting … and arguably biopiracy … is already occurring in New Zealand
  • New Zealand has a number of international obligations to consider
  • Other countries are already taking action
  • If we do not consider this issue, we may miss out on benefits and opportunities

Slide 21: Acknowledgements

Many thanks to:

  • Kristina Ryan, MFAT
  • Caron Mounsey-Smith, MED
  • Dr Mere Roberts, University of Auckland
  • Dr Basil Sharp, University of Auckland
  • Also thank you to Dave Pattemore, Masters student, University of Auckland, for the fabulous photograph of Codfish Island
Back to Top